Deep Brain Stimulation Market is expected to rise from its initial estimated value of USD 888.20 million to an estimated value of USD 2138.63 million by 2026, registering a CAGR of 11.61% in the forecast period of 2019-2026. Rising Parkinson’s disease is the major factor for the growth of this market.
Deep brain stimulation market research report works as a best solution to know the trends and opportunities in the medical device industry. This report not only offers actionable market insights but also lend a hand to create sustainable and money-spinning business strategies. The market report has been specially designed by keeping in mind the customer requirements with which businesses can get assistance in increasing their return on investment (ROI). The report includes top to bottom analysis and evaluation of various market related factors that plays a key role for better decision making. deep brain stimulation report delivers an extensive research on the current conditions of the industry, potential of the market in the present and the future prospects from various point of views.
Ask For Complimentary Sample PDF| Request At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-deep-brain-stimulation-market
Key Market Competitors:
Few of the major competitors currently working in the deep brain stimulation market are Medtronic, Boston Scientific Corporation, Abbott., Cyberonics, Inc., Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Synapse Biomedical Inc., Neuronetics., ReShape Lifesciences, Inc., Cyberonics, Inc., Zynex Medical, Functional Neuromodulation Ltd., MicroTransponder Inc., Aleva Neurotherapeutics SA.
Key Developments in the Market:
In February 2019, Medtronic announced the launch of their new deep brain stimulation (DBS) which is specially designed for medically-refractory epilepsy. The main aim of the launch is to provide better surgical treatment option to the treatment.
In January 2019, Boston Scientific Corporation announced the launch of their Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems which is specially designed to control the shape, position, range and direction and treat the symptoms of Parkinson’s disease (PD). These devices are small in size and usually have long rechargeable battery life. The main of the device is to provide good therapy to the patients.
Global deep brain stimulation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of deep brain stimulation market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Deep Brain Stimulation Market
Obsessive-Compulsive Disorder (OCD)
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
Globus Pallidus DBS
Pedunculopontine nucleus DBS
Middle East & Africa
Inquire Regarding This Report https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-deep-brain-stimulation-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
Email: [email protected]